Affordable Access

Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML.

Authors
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 1 Department of Molecular Haematology, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, United Kingdom.
  • 2 Department of Molecular Haematology, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, United Kingdom.
  • 3 Department of Molecular Haematology, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, United Kingdom.
  • 4 Department of Haematology, Norfolk and Norwich University Hospitals NHS Trust, Colney Lane, Norwich United Kingdom.
  • 5 Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
  • 6 Department of Molecular Haematology, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, United Kingdom. Department of Haematology, Norfolk and Norwich University Hospitals NHS Trust, Colney Lane, Norwich United Kingdom.
  • 7 Department of Molecular Haematology, Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, United Kingdom.
Type
Published Article
Journal
Oncotarget
1949-2553
Publisher
"Impact Journals, LLC "
Publication Date
Volume
5
Issue
20
Pages
9930–9938
Identifiers
PMID: 25294819
Source
Medline

Abstract

Statistics

Seen <100 times